Target intelligence / Profile preview

Adipogenesis regulatory factor (ADIRF)

Target
ADIRF
Molecular classification
Other (small protein, not a classic receptor, enzyme, transporter, or transcription factor)
01

Overview

Adipogenesis regulatory factor (ADIRF) is a small protein predominantly expressed in adipose (fat) tissue, where it plays an important role in promoting differentiation of preadipocytes into mature adipocytes by inducing expression of key transcription factors such as PPARG and CEBPA at early stages of adipogenesis[2][4]. It is not a classical receptor, enzyme, or transcription factor. Its functions are closely tied to fat cell biology, with potential connections to cancer therapy response—specifically, its overexpression is associated with resistance to the chemotherapeutic drug cisplatin[2][5]. Although highly specific to adipose tissue, its complete physiological functions and mechanisms remain incompletely characterized.

Other names
Adipogenesis regulatory factorADIRFAFROAPM2C10orf116apM-2Adipogenesis factor rich in obesityAdipose most abundant gene transcript 2 proteinAdipose-specific protein 2adipose specific 2adipose most abundant gene transcript 2adipogenesis factor rich in obesity
02

Mechanism of action

Not established as a drug target; cisplatin resistance appears to be via an indirect mechanism, details unclear

03

Biological functions

Positive regulation of adipogenic (fat cell) differentiationStimulation of transcription initiation of master adipogenesis factors (PPARG, CEBPA)Cell differentiation
04

Disease associations

Cancer (marker for cisplatin sensitivity)Potential metabolic roles in obesity and fat-cell development
05

Safety considerations

None established as it is not a current therapeutic target
06

Interacting drugs

Cisplatin (resistance conferred by overexpression)
07

Biomarkers

Adipose most abundant 2 protein (ADIRF protein itself) is a predictive marker for cisplatin sensitivity in cancers[5]

Beyond the preview

Go deeper on Adipogenesis regulatory factor (ADIRF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adipogenesis regulatory factor (ADIRF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call